9 results match your criteria: "Higashi Osaka Medical Center[Affiliation]"
Eur J Cancer
December 2024
Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan.
Objective: Potential benefit of surgical resection for liver metastasis from gastric cancer (LMGC) remains controversial because most previous studies were retrospective. We evaluated the outcomes of surgical resection following chemotherapy for LMGC in a prospective single-arm multicenter interventional study.
Methods: Patients with synchronous or metachronous LMGC received 2-4 cycles of standard chemotherapy and proceeded to surgical resection if restaging showed a non-progressive disease with a chance of R0 resection.
Br J Cancer
April 2024
Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan.
Background: No reliable marker has been identified to predict postoperative recurrence of gastric cancer. We designed a clinical trial to investigate the utility of serum NY-ESO-1 antibody responses as a predictive marker for postoperative recurrence in gastric cancer.
Methods: A multicenter prospective study was conducted between 2012 and 2021.
Surg Today
November 2023
Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, 2-15 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Purpose: As the number of long-term survivors of pancreatic cancer is expected to increase thanks to recent advances in multidisciplinary treatment and earlier diagnoses of pancreatic cancer, we are likely to encounter more cases of postoperative pulmonary nodules. We analyzed the clinical course and prognosis of resection of pulmonary metastases from pancreatic cancer to clarify the prognostic implication of pulmonary metastasectomy for pancreatic cancer.
Method: We retrospectively analyzed 35 patients who underwent resection of lung metastases after pancreatic cancer surgery.
Cureus
January 2023
Emergency and General Internal Medicine, Rakuwakai Marutamachi Hospital, Kyoto, JPN.
Eur Heart J Case Rep
November 2022
Department of Cardiology, Higashi-Osaka Medical Center, 3-4-5 Nishi-Iwata, Higashiosaka, Osaka, 578-8588Japan.
Background: Some adults suffer sudden cardiac death after previous surgical repair of tetralogy of Fallot (TOF), and in such cases, ventricular tachycardia is believed to be the most frequent cause of death. However, we report a case of cardiac arrest due to paroxysmal complete atrioventricular block in an adult with dextrocardia and repaired TOF.
Case Summary: A 49-year-old woman with dextrocardia and a history of surgical treatment for TOF lost consciousness three times.
Ann Thorac Cardiovasc Surg
June 2022
Department of Cardiovascular Surgery, Higashi Osaka Medical Center, Higashiosaka, Osaka, Japan.
Intraoperative bleeding from the distal anastomotic site during graft replacement of the arch to distal arch via median sternotomy to treat an aortic aneurysm is sometimes difficult to control because of the limited distal view. I herein report a case in which I addressed this uncontrollable bleeding using a commercialized frozen elephant trunk.
View Article and Find Full Text PDFAnn Surg Oncol
February 2022
Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan.
Background: The optimal treatment for liver metastasis from gastric cancer (LMGC) remains uncertain. The relevance of surgical resection is controversial. We conducted a prospective multicenter interventional study of surgical resection for LMGC.
View Article and Find Full Text PDFGastric Cancer
May 2018
Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2-E2, Yamadaoka, Suita, Osaka, 565-0871, Japan.
Background: Surgical resection with S-1 adjuvant chemotherapy (AC) is the standard of care for stage II-III gastric cancer (GC). However, it is unclear if time to initiation and duration of S-1 AC impact on survival.
Methods: A multi-institutional GC database identified 498 patients who were treated with S-1 AC after D2 or more extended radical surgery for stage II-III gastric cancer.